Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-25-000396
Filing Date
2025-01-02
Accepted
2025-01-02 17:20:09
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D  
1 primary_doc.xml SCHEDULE 13D 13984
2 EXHIBIT 99.1 tm2432203d1_ex99-1.htm EX-99.1 8894
  Complete submission text file 0001104659-25-000396.txt   24486
Mailing Address 23 HATA'AS STREET KFAR SABA L3 44425
Business Address 23 HATA'AS STREET KFAR SABA L3 44425 97299741444
Quoin Pharmaceuticals, Ltd. (Subject) CIK: 0001671502 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: SCHEDULE 13D | Act: 34 | File No.: 005-89873 | Film No.: 25503023
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address AZRIELI CENTER ROUND TOWER, 30TH FLOOR TEL AVIV L3 6701101
Business Address
Myers Michael (Filed by) CIK: 0001959547 (see all company filings)

Type: SCHEDULE 13D